公司股价表现 - 公司股价最近为$390.96，较前一个交易日上涨了+1.04% [1] - 公司股价表现优于标普500指数的日涨幅0.15% [1] - 公司股价在过去一个月内上涨了2.12%，超过了医疗行业的下跌4.03%和标普500指数的上涨1.65% [2] 财务预测 - 公司计划在2024年4月18日公布财报，预计每股收益为$1.40，同比增长13.82%，营收预计为$1.86亿，同比增长9.94% [3] - Zacks Consensus Estimates预计公司全年每股收益为$6.18，营收为$79.7亿，同比增长分别为+8.23%和+11.86% [4] 评级和估值 - 公司目前的Zacks Rank为3 (Hold)，Forward P/E比率为62.63，高于行业平均值26.4 [7],[8] - 公司的PEG比率为4.8，高于医疗仪器行业的平均值2.4 [9] 行业排名和表现 - 医疗仪器行业属于医疗领域，目前行业排名为90，位于所有250+行业的前36% [10] - Zacks Industry Rank显示，排名前50%的行业的表现比排名后50%的行业好2倍 [11]

A price target of $462 might seem ambitious, but it certainly seems achievable.When it comes to robotic-assisted surgery, no one holds a candle to Intuitive Surgical (ISRG 0.28%), a technological leader and pioneer in the field. The company's da Vinci platform is the gold standard in robot-assisted laparoscopic surgery. Being at the top of its field has been lucrative for investors, as the stock has surged 51% over the past year.One Wall Street analyst believes there's still plenty of upside ahead.Numerous ...

公司股价表现 - Intuitive Surgical, Inc. (ISRG) 最新收盘价为$383.42，较前一天上涨了+0.28%[1] - 过去一个月，公司股价下跌了1.28%，超过了医疗行业的1.51%的跌幅，但落后于标普500指数的1.5%的涨幅[2] 财务预期 - 投资者应关注Intuitive Surgical, Inc.即将发布的财报。预计公司每股收益为$1.39，同比增长13.01%；预计营收为18.6亿美元，同比增长9.94%[3] - ISRG全年Zacks共识预期为每股盈利6.18美元，营收为79.7亿美元，同比分别增长8.23%和11.86%[4] 分析师预期和评级 - 分析师对Intuitive Surgical, Inc.的最新预期变动可能反映了短期业务趋势的变化，正面的预期修订表明分析师对公司业绩和利润潜力的信心[5] - Zacks Rank系统从1（强烈买入）到5（强烈卖出），自1988年以来，1股票的年均回报率为+25%。目前，Intuitive Surgical, Inc.的Zacks Rank为3（持有）[7] 行业比较 - 目前，Intuitive Surgical, Inc.的前瞻市盈率为61.9，较其行业平均前瞻市盈率24.98高出很多[8] - ISRG目前的PEG比率为4.74，较医疗器械行业的平均PEG比率2.35高出很多[9] 行业排名 - 医疗器械行业属于医疗行业，目前的Zacks行业排名为64，位于所有行业的前26%[10] - Zacks行业排名通过测量组内个股的平均Zacks Rank来评估我们行业群体的实力。研究显示，排名前50%的行业的表现是排名后50%的两倍[11]

If You Invested $5000 In Intuitive Surgical 10 Years Ago, This Is How Rich You Would Be Today VCG / Getty Images One of the time-tested investment methods is the “buy and hold strategy”. Popularized by investment guru Warren Buffett, this strategy attempts to take emotion out of market peaks and valleys, and relies on holding the stock while the fundamentals of the company’s finances, management, and business model all remain solid, so that the underlying value will be recognized. 24/7 Wall St. has tracke ...

机器人技术应用 - 机器人技术有望改变各行业，特别是制造业和医疗保健领域，通过自动化和效率创造新机会[1] - 人工智能的崛起可能会在这一蓬勃发展的领域带来更多效率，机器人技术有望进入高速增长阶段[2] Symbotic公司发展 - Symbotic是自动化仓储解决方案领域的领导者，利用人工智能优化货物的存储、检索和运输，公司的收入自2020年以来连续翻倍，管理层预计随着更多产品的部署，将有更多的重复收入和顶线可预测性[3] - Symbotic在2023年以惊人的98%的年增长率结束，公司目前以约13.8倍的前销售额交易[4] Intuitive Surgical公司业绩 - Intuitive Surgical是机器人辅助手术领域的先驱和市场领导者，其旗舰产品da Vinci手术系统使外科医生能够进行微创手术，公司持续经历着年度记录增长[5] - Intuitive Surgical在最近的第四季度财报中超过了华尔街对收入和每股收益的预期，da Vinci手术系统的高销量最终导致公司报告的高业绩数字[6] UiPath公司发展 - UiPath虽然是一家软件公司，但在这份机器人名单中也值得一提，该公司创建和实施软件，允许客户使用机器人流程自动化和人工智能来自动化各种业务流程[7] - UiPath在2023年第四季度的收入增长了31%，年度重复收入增长了22%，公司也在第四季度实现了作为上市公司的首次GAAP盈利[8]

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Intuitive Surgical, Inc. (ISRG) . This company, which is in the Zacks Medical - Instruments industry, shows potential for another earnings beat.When looking at the last two reports, this company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 6.19%, on average, in the last two ...

Intuitive Surgical（NASDAQ:ISRG） - ISRG是全球微创护理领域的领导者，是机器人辅助手术的先驱[2] - ISRG在2023年第四季度经历了出色的增长，收入达到19.3亿美元，同比增长16.51%[3] Nvidia（NASDAQ:NVDA） - Nvidia是全球最大的GPU设计和供应商之一，目前是世界上最快的GPU供应商[5] - Nvidia在2023年取得了强劲的财务业绩，收入从2022年的269.74亿美元增长到609.22亿美元，增长了125.85%[6] Kratos（NASDAQ:KTOS） - Kratos是一家提供各种国防解决方案的技术公司，专注于无人机系统[8] - Kratos在2023年第四季度报告了27.38亿美元的收入，同比增长9.8%，EBITDA也大幅增长[9] - Kratos最近赢得了多项政府合同，显示了公司对增长的承诺[10] - 空军正在测试Kratos的自主无人机，暗示可能会签署重要的未来合同[11]

Intuitive Surgical (ISRG -0.25%) is a healthcare company with the potential to help transform an industry with its robotic-assisted surgical systems. By making surgeries easier and more precise for surgeons, they can improve outcomes for patients and help drive efficiency in the industry as well.The company has experienced incredible growth over the years, and it has the potential to become much larger and more valuable in the future. But is there enough upside here for this stock to be a millionaire-making ...

Over the past five years, Intuitive Surgical (ISRG -0.04%) has gone through numerous trials and tribulations. The pandemic significantly disrupted its operations, initially leading to worse financial results than hoped. Various economic issues, including supply chain problems, have also affected Intuitive Surgical in the past half a decade. Still, the medical device specialist has delivered solid returns during this period.Though Intuitive Surgical still has some challenges to deal with (more on that later) ...

When seeking out potential investments, focusing on growth stocks can be a lucrative strategy for investors. Innovative companies with solid growth prospects often outperform the market, as represented by the S&P 500 index. While such companies typically come with a premium price tag, the allure of multibagger gains makes growth stocks attractive for many long-term investors. For instance, the Vanguard Growth ETF (NYSEARCA:VUG), an exchange-traded fund (ETF) giving exposure to large-cap U.S. growth stocks, ...